絲聚蛋白(FLG)重組蛋白
Recombinant Filaggrin (FLG)
Profilaggrin
- 編號(hào)URPJ103Hu03
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位細(xì)胞質(zhì)
- 預(yù)測分子量37.2kDa
- 實(shí)際分子量44&26&20kDa(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽Arg3049~Ala3361 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點(diǎn)10.3
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 966 ¥ 2415 ¥ 4830 ¥ 14490 ¥ 36225
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPJ103Hu02 | 絲聚蛋白(FLG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPJ103Hu01 | 絲聚蛋白(FLG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPJ103Hu05 | 絲聚蛋白(FLG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPJ103Hu61 | 絲聚蛋白(FLG)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPJ103Hu03 | 絲聚蛋白(FLG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPJ103Hu04 | 絲聚蛋白(FLG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAJ103Hu01 | 絲聚蛋白(FLG)多克隆抗體 | WB |
| UPAJ103Hu02 | 絲聚蛋白(FLG)多克隆抗體 | WB; IHC; ICC; IP. |
| ULAJ103Hu71 | 絲聚蛋白(FLG)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| ULAJ103Hu83 | 絲聚蛋白(FLG)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| ULAJ103Hu81 | 絲聚蛋白(FLG)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| UMAJ103Hu21 | 絲聚蛋白(FLG)單克隆抗體 | WB; IHC; ICC; IP. |
| USEJ103Hu | 絲聚蛋白(FLG)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCJ103Hu | 絲聚蛋白(FLG)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMJ103Hu | 絲聚蛋白(FLG)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Journal of the Egyptian Women's Dermatologic Society | Filaggrin R501x and 2282del4 gene mutations and its tissue levels in patients with chronic plaque psoriasis [LWW: 01000] |
| ?Inflammation & Allergy-Drug Targets | Neuromodulatory and Anti-Inflammatory Ingredient for Sensitive Skin: In Vitro Assessment [Pubmed:24931812] |
| PLoS?One | Protective Effects of Triphala on Dermal Fibroblasts and Human Keratinocytes [Pubmed:26731545] |
| Journal of food biochemistry | In vitro anti-inflammatory and skin protective properties of extract comprising ceramides from de-oiled rice bran [doi:10.1111] |
| European Journal of Pharmacology | Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. [pubmed:28736282] |
| Journal of Dermatological?Science | A novel, topical, nonsteroidal, TRPV1 antagonist, PAC-14028 cream improves skin barrier function and exerts anti-inflammatory action through modulating epidermal?… [Pubmed:29752146] |
| Journal of Traditional and Complementary Medicine | In vitro anti-inflammatory and skin protective properties of Virgin coconut oil [10.1016:j.jtcme.2017.06.012] |
| Clinical and Molecular Allergy | Markers of atopic dermatitis, allergic rhinitis and bronchial asthma in pediatric patients: correlation with filaggrin, eosinophil major basic protein and?… [] |
| Intractable?&?Rare?Diseases?Research | Filaggrin, major basic protein and leukotriene B4: Biomarkers for adult patients of bronchial asthma, atopic dermatitis and allergic rhinitis [Pubmed: 30560019] |
| Dermatology and Therapy | Epidermal and Dermal Hallmarks of Photoaging are Prevented by Treatment with Night Serum Containing Melatonin, Bakuchiol, and Ascorbyl?… [] |
| 日本化粧品技術(shù)者會(huì)誌 | 糖化に起因する表皮機(jī)能低下に対するワイルドタイムエキスの防御効果 [] |
| J Dermatol | Filaggrin‐gene mutation has minimal effect on the disease severity in the lesions of atopic dermatitis [34322929] |
留言咨詢
